# The Biomedical Publications Industry Must Change to Better Serve the Needs of Science and Scientists

**Authors:** Michael M. Lederman, Neil S. Greenspan

PMC · DOI: 10.20411/pai.v10i2.819 · Pathogens and Immunity · 2025-03-31

## TL;DR

The paper argues that the biomedical publishing industry is too complex and costly, and needs to change to better support science and scientists.

## Contribution

The paper provides critiques of the biomedical publishing industry and suggests ways to improve it.

## Key findings

- The biomedical publishing industry has become unnecessarily complex and expensive.
- The current state of the industry impedes the sharing of research findings.
- Reforms are needed to better serve the needs of science and scientists.

## Abstract

The biomedical publications industry is vital to progress in science and health care. We observe that this industry has become unnecessarily complex and expensive for researchers and readers, impeding the sharing of research findings. In this perspective, we offer selected critiques of this industry and suggest how it might be improved.

## Full-text entities

- **Diseases:** DISTRIBUTION (MESH:D020243), SUBMISSION PROCESSES (MESH:D010335), POTENTIAL (MESH:C537245)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12011323/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12011323/full.md

---
Source: https://tomesphere.com/paper/PMC12011323